loadpatents
name:-0.0073831081390381
name:-0.049560070037842
name:-0.0009610652923584
Tolman; Richard L. Patent Filings

Tolman; Richard L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tolman; Richard L..The latest application filed is for "oligonucleotide conjugates".

Company Profile
0.50.7
  • Tolman; Richard L. - Incline Village NV
  • Tolman; Richard L. - Carson City NV
  • Tolman; Richard L. - Los Altos CA
  • Tolman, Richard L. - Menlo Park CA
  • Tolman; Richard L. - Warren NJ
  • Tolman; Richard L. - Berkeley Heights NJ
  • Tolman; Richard L. - Berkley Heights NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Oligonucleotide conjugates
Grant 9,572,891 - Gryaznov , et al. February 21, 2
2017-02-21
Oligonucleotide Conjugates
App 20150374841 - Gryaznov; Sergei M. ;   et al.
2015-12-31
Oligonucleotide conjugates
Grant 9,072,790 - Gryaznov , et al. July 7, 2
2015-07-07
Oligonucleotide Conjugates
App 20130253042 - Gryaznov; Sergei M. ;   et al.
2013-09-26
Oligonucleotide conjugates
Grant 8,440,635 - Gryaznov , et al. May 14, 2
2013-05-14
Oligonucleotide Conjugates
App 20100016416 - Gryaznov; Sergei ;   et al.
2010-01-21
Oligonucleotide conjugates
Grant 7,563,618 - Gryaznov , et al. July 21, 2
2009-07-21
4-Azasteroids for treatment of hyperandrogenic conditions
Grant RE39,056 - Bakshi , et al. April 4, 2
2006-04-04
Oligonucleotide conjugates
App 20030138814 - Gryaznov, Sergei ;   et al.
2003-07-24
Pharmaceuticals for treating obesity
App 20030032581 - Berger, Joel P. ;   et al.
2003-02-13
Telomerase inhibitors and methods of their use
Grant 6,518,268 - Chin , et al. February 11, 2
2003-02-11
Telomerase inhibitors and methods of their use
Grant 6,452,014 - Akama , et al. September 17, 2
2002-09-17
Telomerase inhibitors and methods of their use
App 20020120144 - Akama, Tsutomu ;   et al.
2002-08-29
Substituted indole compounds and methods of their use
App 20020115700 - Chin, Allison C. ;   et al.
2002-08-22
Antidiabetic agents
Grant 6,090,839 - Adams , et al. July 18, 2
2000-07-18
Arylthiazolidinedione derivatives
Grant 6,008,237 - Sahoo , et al. December 28, 1
1999-12-28
4-Azasteroids for treatment of hyperandrogenic conditions
Grant 6,001,844 - Bakshi , et al. December 14, 1
1999-12-14
16-pyrazinyl-substituted-4-aza-androstane 5-.alpha.-reductase isozyme 1 inhibitors
Grant 5,910,497 - Durette , et al. June 8, 1
1999-06-08
Antidiabetic agents
Grant 5,859,051 - Adams , et al. January 12, 1
1999-01-12
Inhibitors of peptide binding to MHO class II proteins
Grant 5,817,757 - Adams , et al. October 6, 1
1998-10-06
4-oxa and 4-thia steriods
Grant 5,777,134 - Bakshi , et al. July 7, 1
1998-07-07
Substituted 4-aza-5.alpha.-androstan-ones as 5.alpha.-reductase inhibitors
Grant 5,693,809 - Durette , et al. December 2, 1
1997-12-02
Pneumococcal polysaccharide conjugate vaccine
Grant 5,623,057 - Marburg , et al. April 22, 1
1997-04-22
Ester derivatives of 4-aza-steroids
Grant 5,610,162 - Witzel , et al. March 11, 1
1997-03-11
17-Ethers and thioethers of 4-aza-steroids
Grant 5,536,727 - Witzel , et al. July 16, 1
1996-07-16
17.beta.-substituted-6-azasteroid derivatives useful as 5.alpha.-reductase inhibitors
Grant 5,516,779 - Von Langen , et al. May 14, 1
1996-05-14
Delta-17 and delta-20 olefinic and saturated 17 beta-substituted 4-aza-5 alpha-androstan-ones as 5 alpha reductase inhibitors useful in the prevention and treatment of hyperandrogenic disorders
Grant 5,510,351 - Graham , et al. * April 23, 1
1996-04-23
Protein-dimeric polysaccharide conjugate vaccine
Grant 5,371,197 - Marburg , et al. December 6, 1
1994-12-06
17.beta.-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5.alpha.-reductase inhibitors
Grant 5,196,411 - Rasmusson , et al. March 23, 1
1993-03-23
Antiherpetic agents
Grant 5,110,799 - Tolman , et al. May 5, 1
1992-05-05
Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
Grant 5,057,517 - Johnston , et al. October 15, 1
1991-10-15
Piperazinylpyrimidines as .beta.-adrenergic receptor blockers
Grant 4,994,464 - Tolman , et al. February 19, 1
1991-02-19
Method for determining the functionalization of a solid support
Grant 4,988,625 - Marburg , et al. January 29, 1
1991-01-29
Piperazinylalkylpyrimidines as hypoglycemic agents
Grant 4,980,350 - MacCoss , et al. December 25, 1
1990-12-25
7,8-dihydro-4-(1-pierazinyl)-6H-thiopyrano-[3,2-d] pyrimidines as .beta.-blockers
Grant 4,889,856 - Tolman , et al. December 26, 1
1989-12-26
Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
Grant 4,882,317 - Marburg , et al. November 21, 1
1989-11-21
Alkylpiperazinylpyridines as hypoglycemic agents
Grant 4,876,256 - Coss , et al. October 24, 1
1989-10-24
Inhibitor of ribonucleotide reductase
Grant 4,845,195 - Colonno , et al. July 4, 1
1989-07-04
Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins and methods of preparing such polysaccharides and conjugates
Grant 4,830,852 - Marburg , et al. * May 16, 1
1989-05-16
Anti-viral guanine compounds
Grant 4,816,447 - Ashton , et al. March 28, 1
1989-03-28
5-Amino or substituted amino 1,2,3-triazoles
Grant 4,816,469 - Bochis , et al. March 28, 1
1989-03-28
Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
Grant 4,801,710 - MacCoss , et al. January 31, 1
1989-01-31
9-(2-hydroxymethyl)cycloalkylmethyl) guanines
Grant 4,782,062 - Tolman , et al. November 1, 1
1988-11-01
Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
Grant 4,695,624 - Marburg , et al. September 22, 1
1987-09-22
Purine derivatives
Grant 4,617,304 - Ashton , et al. October 14, 1
1986-10-14
N-alkylguanine acyclonucleosides as antiviral agents
Grant 4,579,849 - MacCoss , et al. April 1, 1
1986-04-01
Coupled H. influenzae type B vaccine
Grant 4,459,286 - Hilleman , et al. July 10, 1
1984-07-10
Novel process for the preparation of N.sup.6 -alkyl-arprinocid
Grant 4,361,699 - Rasmusson , et al. November 30, 1
1982-11-30
Anovulatory method and chicken feed compositions
Grant 4,287,201 - Olson , et al. September 1, 1
1981-09-01
Preparation of 5-deazariboflavins
Grant 4,277,603 - Tolman , et al. July 7, 1
1981-07-07
Sugar derivatives of C-076 compounds
Grant 4,203,976 - Fisher , et al. May 20, 1
1980-05-20
Alkyl derivatives of C-076 compounds
Grant 4,200,581 - Fisher , et al. April 29, 1
1980-04-29
Carbohydrate derivatives of milbemycin and processes therefor
Grant 4,156,720 - Fisher , et al. May 29, 1
1979-05-29
Heterocyclic substituted imidazo [1,2-a] pyridines
Grant 4,146,642 - Bochis , et al. March 27, 1
1979-03-27
Carbohydrate derivatives of milbemycin and processes therefor
Grant 4,134,973 - Fisher , et al. January 16, 1
1979-01-16
9.beta.-D-Arabinofuranosylpurine nucleotides and method of use
Grant 4,093,714 - Tolman , et al. June 6, 1
1978-06-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed